According to a new report from Intel Market Research, the global gene synthesis market was valued at USD 611 million in 2024 and is projected to reach USD 1,865 million by 2032, growing at an impressive CAGR of 17.7% during the forecast period (2025–2032). This significant expansion is driven by escalating investments in synthetic biology, the...

The global gene synthesis market was valued at USD 2.7 billion in 2025 and is projected to grow from USD 3.1 billion in 2026 to USD 9.3 billion by 2033, registering a compound annual growth rate (CAGR) of 16.7% from 2026 to 2033. North America dominated the market in 2025, accounting for 37.5% of global revenue. Market growth is driven by increasing investments in synthetic biology, supportive...

According to a new report from Intel Market Research, the global Gene Synthesis market was valued at USD 735 million in 2025 and is projected to reach USD 3,200 million by 2034, growing at an exceptional CAGR of 17.8% during the forecast period (2026–2034). This remarkable expansion is driven by accelerating biopharmaceutical R&D, declining costs with increasing throughput,...

The development of advanced genetic research, molecular diagnostics, and nucleic acid-based therapies is increasing the importance of oligonucleotide synthesis in biotechnology. These short DNA or RNA sequences are used in applications ranging from polymerase chain reaction (PCR) testing and DNA sequencing to gene editing and therapeutic development. As pharmaceutical companies and research...

The Gene Synthesis Market is expanding rapidly as synthetic DNA becomes increasingly important across synthetic biology, drug discovery, vaccine development, genetic engineering, and advanced therapeutic research. The market was valued at USD 2.7 billion in 2025 and is projected to grow from USD 3.1 billion in 2026 to USD 9.3 billion by 2033, registering a CAGR of 16.7% from 2026 to 2033....